Pawel Kacperek/iStock via Getty Images
Tarsus Pharmaceuticals (NASDAQ:TARS) has pared some of an earlier gain of as much as 13% and is now up 8% amid a report that Alcon (ALC) interest in a takeover has cooled.
Alcon (ALC) has decided to move on after it